| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $25.83M | - | |
| CEO | 188.2K | $2.07M | - | |
| Other | 99.2K | $1.09M | - | |
| CFO | 84.2K | $928.0K | - | |
| COO | 54.3K | $598.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2019 | White Barbara | Chief Medical Officer | Buy | 3,424 | $4.38 | $14,991.64 | +1.8% | |
| Nov 12, 2019 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,430 | $4.26 | $6,091.80 | +2.2% | |
| Nov 11, 2019 | Millian Craig Stuart | Chief Commercial Officer | Buy | 1,000 | $4.38 | $4,380.00 | +11.1% | |
| Nov 11, 2019 | Discordia Robert Paul | Chief Operating Officer | Buy | 2,500 | $4.62 | $11,558.50 | +8.3% | |
| Aug 15, 2019 | Millian Craig Stuart | Chief Commercial Officer | Buy | 1,500 | $5.48 | $8,212.95 | +20.0% | |
| Aug 12, 2019 | White Barbara | Chief Medical Officer | Buy | 1,639 | $6.10 | $9,997.90 | +0.9% | |
| Aug 12, 2019 | Millian Craig Stuart | Chief Commercial Officer | Buy | 1,500 | $6.00 | $9,000.00 | +25.0% | |
| Aug 12, 2019 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,175 | $6.06 | $7,115.80 | +1.8% | |
| Aug 12, 2019 | Discordia Robert Paul | Chief Operating Officer | Buy | 15,000 | $5.86 | $87,894.00 | +99.0% | |
| May 17, 2019 | White Barbara | Chief Medical Officer | Buy | 1,389 | $7.20 | $10,000.80 | +0.8% |